considered as a distinct clinical subgroup in SjS [1] [2] . The other autoimmune diseases associated with ACA-positive have not fully elucidated and the role of ACA in their pathogenesis still remains unclear. In addition, comprehensive and enough clinical information from the point of view of ACA positive cases has not been accumulated. Objectives: To clarify clinical features of patients with ACA and their association with autoantibodies. Methods: Patients with discrete-speckled pattern in anti-nuclear antibody (ANA) test and/or positive ACA, who visited to our department during over 20 years between May 1995 and December 2016, were enrolled. Clinical information and immunological tests including immunoglobulin (Ig) and serum autoantibodies were collected and statistically analyzed. Results: Discrete-speckled pattern in ANA test and/or positive ACA were identified in 309 patients. There were 292 female and 17 male and the average age was 60 years old. Proportion of concomitant ANA patterns were speckled (16%), homogenous (7%), cytoplasmic (3%) and/or nucleolar (3%) pattern. 186 patients (60%) had Raynaud's phenomenon and 149 patients (48%) had sclerodactyly. 162 patients (52%) had oral and/or ocular dryness symptoms. 21 patients (6%) had interstitial pneumonia and 13 patients (4%) had pulmonary hypertension. 42 patients (13%) had arthritis. 19 patients (6%) had thyroid disease. 214 patients (69%) were classified into 17 autoimmune diseases (including overlap cases) from symptoms at initial visit, while other 95 patients (31%) who did not meet the criteria were not diagnosed. IgG, IgM and IgA in the patients who were classified into autoimmune diseases were higher than that in other patients who were not classified (p=0.0007, p=0.0057 and p=0.0158, respectively). In the 214 patients (69%), there were most of patients who were diagnosed as SSc (n=113, 36%) and/or SjS (n=78, 25%). 25 patients (8%) and 22 patients (7%) were diagnosed with rheumatoid arthritis (RA) and PBC, respectively. On the other hand, the patients who diagnosed as systemic lupus erythematosus were 3 (1%), and nobody was diagnosed as myositis. The mean observation period was 80 months. 2 patients in 95 patients who were unclassified at initial visit were diagnosed as RA or autoimmune hepatitis by developing new symptoms during observation. A patient was newly diagnosed as SSc in addition to SjS because sclerodactyly was newly developed. In other patients, the diagnosis was not changed and added during observation. Conclusions: Our single center longitudinal retrospective cohort study confirmed that ACA-positive cases were classified into various types of autoimmune disease. Few patients had new symptoms during observation but the initial diagnosis was unchanged. Our data demonstrated that initial manifestation determined clinical entity and course in patients with ACA. Background: In most patients with SSc, the onset is in the form of Raynaud's phenomenon (RP), but in a few is in the form of visceral or musculoskeletal involvement or skin sclerosis. Several risk factors are related to poor outcome in patients with SSc, but never before has the mode of onset been described as one of them. Objectives: To asses the mode of onset as prognostic factor in patients with SSc. Methods: A retrospective and multicentre cohort study including 1625 patients with SSc, based on the National Spanish Scleroderma Registry (RESCLE) which includes 28 referral centres. RP, puffy hands, arthralgia/arthritis, skin sclerosis, intersititial lung disease (ILD), pulmonary arterial hypertension (PAH) and esophageal hipomotility where included as clinical modes of onset. Results: The cohort was split up in two groups: 1342 patients (83%) presented as RP and 283 (17%) presented as non-RP (see graphic below) Non-RP patients where younger at onset of disease (44.7±16.5 vs 49±15.6 years, p<0.001), showed higher percentage of diffuse subtipe (36% vs 19%, p<0.001), developed more visceral involvement during the course of the illness and where more frequently anti-RNAp III positive (29 vs 10%, p<0.001). Overall mortality was 16% in patients presented as RP vs 23% in non-RP patients (p=0.003). Few differences where noted among causes of death related to SSc, but the higher mortality was observed in RP group due to PAH (19% vs 8.1%, p=0.05) and due to ILD in non-RP group (24% vs 8.3%, p=0.002). Survival of patients with RP at onset was better at anytime than those with a non-RP onset: 0. 
Conclusions:
The mode of onset can be considered as independent prognostic factor, and specifically non-RP onset can be considered as a risk factor related to poorer outcome and RP onset and arthralgias can be considered as protector factors. Background: Recent studies report on increased serum levels of C-reactive protein (CRP) in systemic scleroderma (SSc) pts. Objectives: The current study was aimed at identifying potential correlations between CRP levels, immunologic SSc phenotypes and CRP rs1205 gene polymorphism in the Russian cohort. Methods: 92 SSc pts were enrolled in the study. Mean age (± SD) was 49,4±12,6 years, mean (± SD) SSc duration was 11,1±9,0 years, increased CRP levels >5 mg/l were documented in 43% pts. CRP levels were analyzed in the following subgroups: with limited (lcSSc) and diffuse (dcSSC) types, with SSc duration <3 years >3, with or without interstitial lung disease (ILD+) and (ILD-), as well as in subgroups with positive antibody titers to DNA topoisomerase I (ATA+) and antibody to centromeres (ACA+). CRP concentrations were measured with highly sensitive immunoturbidimertry method. Allele-specific real time PCR was used to study CRP rs1205 gene polymorphism. Results: Mean CRP (± SD) level was significantly higher in dcSSc vs lcSSc (11,9±15,5 mg/l; vs 4,7±7,4 mg/l, respectively, p=0,006) . Pts with disease duration <3 years had higher mean CRP levels as compared to pts with SSc duration >3 years, although the difference was not significant. In pts with disease duration >3 years mean CRP levels were significantly higher among subjects with dcSSc than lcSSc (11,0±15,5 mg/l vs 4,8±7,7 mg/l, respectively, p=0,027). Mean CRP level was higher in (ATA+) pts than in (ATA-) pts (11,0±15,4 mg/l vs 5,5±13,7 mg/l, respectively, p=0,032). No statistical difference in CRP levels was found between (ILD+) and (ILD-) pts, as well as between (ACA+) and (ACA-) pts. Carriers of rs1205 CC genotype had higher CRP levels than carriers of rs1205 T allele,p=0,087). In pts with SSc duration >3 years and carriers of rs1205 CC genotype mean CRP level was significantly higher than in T-allele carriers (12,0±17,4 mg/l vs 5,4±7,4 mg/l, respectively, p=0,021). Similar trends for CRP levels depending on genotypes were established among (ATA+) pts (16,9±20,1 mg/l and 7,3±10,5 mg/l, respectively, p=0,031). Conclusions: Increased CRP levels were found almost in 50% of Russian SSc pts. Higher CRP levels were associated with specific clinical and immunological SSc parameters and CRP rs1205 CC genotype, signifying unfavorable prognosis. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.2676 FRI0404 THE EFFECT OF A HOME-BASED OROFACIAL EXERCISE
